Intranasal immunization with curdlan induce Th17 responses and enhance protection against enterovirus 71.

[1]  T. D. da Silva,et al.  Adjuvant Curdlan Contributes to Immunization against Cryptococcus gattii Infection in a Mouse Strain-Specific Manner , 2022, Vaccines.

[2]  Sun-Young Chang,et al.  Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors , 2021, Immune network.

[3]  F. H. Damron,et al.  Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice , 2020, Infection and Immunity.

[4]  S. Han,et al.  Intranasal Vaccination with Outer-Membrane Protein of Orientia tsutsugamushi induces Protective Immunity Against Scrub Typhus , 2020, Immune network.

[5]  S. Uematsu,et al.  Development of prime-boost-type next-generation mucosal vaccines. , 2019, International immunology.

[6]  K. Ishii,et al.  Antigen-specific Mucosal Immunity Regulates Development of Intestinal Bacteria-mediated Diseases. , 2019, Gastroenterology.

[7]  X. Guan,et al.  Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase IV study. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  F. H. Damron,et al.  Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia , 2019, Front. Immunol..

[9]  F. H. Damron,et al.  Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis , 2019, npj Vaccines.

[10]  D. Stinchcomb,et al.  An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages. , 2019, Vaccine.

[11]  M. Jit,et al.  Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  Deepjyoti K Das,et al.  Curdlan Limits Mycobacterium tuberculosis Survival Through STAT-1 Regulated Nitric Oxide Production , 2019, Front. Microbiol..

[13]  K. Wong,et al.  Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice , 2019, Scientific Reports.

[14]  Q. Yan,et al.  Curdlan oligosaccharides having higher immunostimulatory activity than curdlan in mice treated with cyclophosphamide. , 2019, Carbohydrate polymers.

[15]  D. Kohane,et al.  PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia. , 2018, Vaccine.

[16]  C. Czerkinsky,et al.  Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain , 2018, Journal of immunology research.

[17]  R. Coler,et al.  Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan , 2018, Front. Immunol..

[18]  T. Aoshi.  Modes of Action for Mucosal Vaccine Adjuvants , 2017, Viral immunology.

[19]  P. Boyaka.  Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems , 2017, The Journal of Immunology.

[20]  Sabrina Barbosa de Souza Ferreira,et al.  Description of recovery method used for curdlan produced by Agrobacterium sp. IFO 13140 and its relation to the morphology and physicochemical and technological properties of the polysaccharide , 2017, PloS one.

[21]  Y. Jang,et al.  The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants , 2017 .

[22]  Sun-Young Chang,et al.  Enterovirus 71 infection and vaccines , 2017, Clinical and experimental vaccine research.

[23]  S. van der Veen,et al.  Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluation , 2016, Scientific Reports.

[24]  M. Jordana,et al.  Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway , 2016, PLoS pathogens.

[25]  Sun-Young Chang,et al.  Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection. , 2015, Vaccine.

[26]  C. Leclerc,et al.  Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. , 2015, The Journal of allergy and clinical immunology.

[27]  L. Mei,et al.  Enterovirus 71 Infection Causes Severe Pulmonary Lesions in Gerbils, Meriones unguiculatus, Which Can Be Prevented by Passive Immunization with Specific Antisera , 2015, PloS one.

[28]  Z. Ku,et al.  A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. , 2014, Vaccine.

[29]  K. Fujii,et al.  Transgenic mouse model for the study of enterovirus 71 neuropathogenesis , 2013, Proceedings of the National Academy of Sciences.

[30]  Pei Liu,et al.  Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial , 2013, The Lancet.

[31]  Yi-Tsung Lin,et al.  A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. , 2013, Vaccine.

[32]  P. Chong,et al.  Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71 , 2013, PloS one.

[33]  W. Liang,et al.  Enterovirus 71-Induced Neurological Disorders in Young Gerbils, Meriones unguiculatus: Development and Application of a Neurological Disease Model , 2012, PloS one.

[34]  H. Nakajima,et al.  β-Glucan Curdlan Induces IL-10–Producing CD4+ T Cells and Inhibits Allergic Airway Inflammation , 2012, The Journal of Immunology.

[35]  C. Elson,et al.  Th17 Cells Upregulate Polymeric Ig Receptor and Intestinal IgA and Contribute to Intestinal Homeostasis , 2012, The Journal of Immunology.

[36]  S. Kim,et al.  Mucosal vaccine adjuvants update , 2012, Clinical and experimental vaccine research.

[37]  P. Aich,et al.  Importance of innate mucosal immunity and the promises it holds , 2011, International journal of general medicine.

[38]  F. Kong,et al.  Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5' untranslated region and VP1 region. , 2011, Journal of medical microbiology.

[39]  J. Kolls,et al.  The role of Th17 cytokines in primary mucosal immunity. , 2010, Cytokine & growth factor reviews.

[40]  Sudhir Gupta,et al.  Human Dendritic Cells Activated via Dectin-1 Are Efficient at Priming Th17, Cytotoxic CD8 T and B Cell Responses , 2010, PloS one.

[41]  Shixia Wang,et al.  EV71: an emerging infectious disease vaccine target in the Far East? , 2010, Vaccine.

[42]  S. Goksugur,et al.  Images in clinical medicine. Hand, foot, and mouth disease. , 2010, The New England journal of medicine.

[43]  S. Khader,et al.  Th17 cytokines in mucosal immunity and inflammation , 2010, Current opinion in HIV and AIDS.

[44]  H. Ochs,et al.  IL-10 Deficiency Unleashes an Influenza-Specific Th17 Response and Enhances Survival against High-Dose Challenge1 , 2009, The Journal of Immunology.

[45]  David L. Williams,et al.  Internalization of Dectin-1 terminates induction of inflammatory responses , 2009, European journal of immunology.

[46]  F. Osorio,et al.  Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. , 2008, Blood.

[47]  J. Kolls,et al.  Th17 cytokines and mucosal immunity , 2008, Immunological reviews.

[48]  M. Netea,et al.  Dectin‐1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages , 2008, Cellular microbiology.

[49]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[50]  M. Cesta.  Normal Structure, Function, and Histology of Mucosa-Associated Lymphoid Tissue , 2006, Toxicologic pathology.

[51]  Shizuo Akira,et al.  Innate immune recognition of viral infection , 2006, Nature Immunology.

[52]  P. Kozlowski,et al.  Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.

[53]  M. Neurath,et al.  The role of Th1/Th2 polarization in mucosal immunity , 2002, Nature Medicine.

[54]  M. Boes,et al.  Role of natural and immune IgM antibodies in immune responses. , 2000, Molecular immunology.

[55]  M. Katayama,et al.  Effects of curdlan and gellan gum on the surface structure of intestinal mucosa in rats. , 1997, Journal of nutritional science and vitaminology.

[56]  Yi Wang,et al.  Mucosal vaccines: Strategies and challenges. , 2020, Immunology letters.

[57]  S. Gordon,et al.  Dectin-1 is required for β-glucan recognition and control of fungal infection , 2007, Nature Immunology.